Panbela Therapeutics, Inc. (OTCMKTS:PBLA – Get Free Report)’s share price passed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $0.01 and traded as low as $0.0002. Panbela Therapeutics shares last traded at $0.0002, with a volume of 348 shares trading hands.
Panbela Therapeutics Trading Down 98.2%
The firm’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.01. The stock has a market capitalization of $971.00, a price-to-earnings ratio of -0.00 and a beta of 42.77.
About Panbela Therapeutics
Panbela Therapeutics, Inc is a biotechnology company focused on developing novel therapies for cancer and other serious diseases. The company’s research has centered on treatments that target polyamine metabolism, a biological process associated with tumor growth and cancer progression.
Panbela’s lead investigational product has been ivospemin, formerly known as SBP-101, which has been studied in combination with standard treatments for pancreatic ductal adenocarcinoma and other solid tumors.
Featured Stories
- Five stocks we like better than Panbela Therapeutics
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Panbela Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Panbela Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
